List of Tables
    Table 1. Plasma Derived Medicine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Plasma Derived Medicine Market Trends
    Table 3. Plasma Derived Medicine Market Drivers
    Table 4. Plasma Derived Medicine Market Challenges
    Table 5. Plasma Derived Medicine Market Restraints
    Table 6. Global Plasma Derived Medicine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Plasma Derived Medicine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Plasma Derived Medicine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Plasma Derived Medicine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Plasma Derived Medicine Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Plasma Derived Medicine Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Plasma Derived Medicine Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Plasma Derived Medicine Sales by Manufacturer, (K MT), 2017-2022
    Table 14. Global Plasma Derived Medicine Sales Share by Manufacturer, 2017-2022
    Table 15. Global Plasma Derived Medicine Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Plasma Derived Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Plasma Derived Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Derived Medicine as of 2021)
    Table 18. Top Players of Plasma Derived Medicine in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Plasma Derived Medicine Product Type
    Table 20. Date of International Manufacturers Enter into Plasma Derived Medicine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Plasma Derived Medicine Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Plasma Derived Medicine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Plasma Derived Medicine Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Plasma Derived Medicine Sales by Players, (K MT), 2020, 2021 & 2022
    Table 26. United States Plasma Derived Medicine Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Plasma Derived Medicine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Plasma Derived Medicine Sales in Volume by Region (2017-2022) & (K MT)
    Table 29. Global Plasma Derived Medicine Sales in Volume Forecast by Region (2023-2028) & (K MT)
    Table 30. Global Plasma Derived Medicine Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Plasma Derived Medicine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Plasma Derived Medicine Sales in Volume by Country (2017-2028) & (K MT)
    Table 33. North America Plasma Derived Medicine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Plasma Derived Medicine Sales in Volume by Region (2017-2028) & (K MT)
    Table 35. Asia Pacific Plasma Derived Medicine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Plasma Derived Medicine Sales in Volume by Country (2017-2028) & (K MT)
    Table 37. Europe Plasma Derived Medicine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Plasma Derived Medicine Sales in Volume by Country (2017-2028) & (K MT)
    Table 39. Latin Americaa Plasma Derived Medicine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Plasma Derived Medicine Sales in Volume by Country (2017-2028) & (K MT)
    Table 41. Middle East and Africa Plasma Derived Medicine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Grifols Corporation Information
    Table 43. Grifols Description and Business Overview
    Table 44. Grifols Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. Grifols Plasma Derived Medicine Product
    Table 46. Grifols Recent Development
    Table 47. SK Plasma Corporation Information
    Table 48. SK Plasma Description and Business Overview
    Table 49. SK Plasma Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. SK Plasma Product
    Table 51. SK Plasma Recent Development
    Table 52. Fusion Health Care Corporation Information
    Table 53. Fusion Health Care Description and Business Overview
    Table 54. Fusion Health Care Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Fusion Health Care Product
    Table 56. Fusion Health Care Recent Development
    Table 57. Biotest AG Corporation Information
    Table 58. Biotest AG Description and Business Overview
    Table 59. Biotest AG Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. Biotest AG Product
    Table 61. Biotest AG Recent Development
    Table 62. GC Pharma Corporation Information
    Table 63. GC Pharma Description and Business Overview
    Table 64. GC Pharma Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. GC Pharma Product
    Table 66. GC Pharma Recent Development
    Table 67. Baxter International Corporation Information
    Table 68. Baxter International Description and Business Overview
    Table 69. Baxter International Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. Baxter International Product
    Table 71. Baxter International Recent Development
    Table 72. LFB Corporation Information
    Table 73. LFB Description and Business Overview
    Table 74. LFB Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. LFB Product
    Table 76. LFB Recent Development
    Table 77. Octapharma AG Corporation Information
    Table 78. Octapharma AG Description and Business Overview
    Table 79. Octapharma AG Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 80. Octapharma AG Product
    Table 81. Octapharma AG Recent Development
    Table 82. CSL Limited Corporation Information
    Table 83. CSL Limited Description and Business Overview
    Table 84. CSL Limited Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 85. CSL Limited Product
    Table 86. CSL Limited Recent Development
    Table 87. BPL Corporation Information
    Table 88. BPL Description and Business Overview
    Table 89. BPL Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 90. BPL Product
    Table 91. BPL Recent Development
    Table 92. China Biologic Products Corporation Information
    Table 93. China Biologic Products Description and Business Overview
    Table 94. China Biologic Products Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 95. China Biologic Products Product
    Table 96. China Biologic Products Recent Development
    Table 97. Kedrion Biopharma Corporation Information
    Table 98. Kedrion Biopharma Description and Business Overview
    Table 99. Kedrion Biopharma Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 100. Kedrion Biopharma Product
    Table 101. Kedrion Biopharma Recent Development
    Table 102. RAAS Corporation Information
    Table 103. RAAS Description and Business Overview
    Table 104. RAAS Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 105. RAAS Product
    Table 106. RAAS Recent Development
    Table 107. Tiantan Bio Corporation Information
    Table 108. Tiantan Bio Description and Business Overview
    Table 109. Tiantan Bio Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 110. Tiantan Bio Product
    Table 111. Tiantan Bio Recent Development
    Table 112. Hualan Biological Engineering Corporation Information
    Table 113. Hualan Biological Engineering Description and Business Overview
    Table 114. Hualan Biological Engineering Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 115. Hualan Biological Engineering Product
    Table 116. Hualan Biological Engineering Recent Development
    Table 117. BOYA Bio-Pharmaceutical Corporation Information
    Table 118. BOYA Bio-Pharmaceutical Description and Business Overview
    Table 119. BOYA Bio-Pharmaceutical Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 120. BOYA Bio-Pharmaceutical Product
    Table 121. BOYA Bio-Pharmaceutical Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Plasma Derived Medicine Customers List
    Table 125. Plasma Derived Medicine Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Plasma Derived Medicine Product Picture
    Figure 2. Global Plasma Derived Medicine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Plasma Derived Medicine Market Size 2017-2028 (US$ Million)
    Figure 4. Global Plasma Derived Medicine Sales 2017-2028 (K MT)
    Figure 5. United States Plasma Derived Medicine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Plasma Derived Medicine Market Size 2017-2028 (US$ Million)
    Figure 7. United States Plasma Derived Medicine Sales 2017-2028 (K MT)
    Figure 8. United States Plasma Derived Medicine Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Plasma Derived Medicine Market Share in Global, in Volume (K MT) 2017-2028
    Figure 10. Plasma Derived Medicine Report Years Considered
    Figure 11. Product Picture of Albumin
    Figure 12. Product Picture of Coagulation Factor
    Figure 13. Product Picture of Immunoglobulin
    Figure 14. Product Picture of Others
    Figure 15. Global Plasma Derived Medicine Market Share by Type in 2022 & 2028
    Figure 16. Global Plasma Derived Medicine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Plasma Derived Medicine Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Plasma Derived Medicine Sales by Type (2017-2028) & (K MT)
    Figure 19. Global Plasma Derived Medicine Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Plasma Derived Medicine Price by Type (2017-2028) & (USD/MT)
    Figure 21. United States Plasma Derived Medicine Market Share by Type in 2022 & 2028
    Figure 22. United States Plasma Derived Medicine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Plasma Derived Medicine Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Plasma Derived Medicine Sales by Type (2017-2028) & (K MT)
    Figure 25. United States Plasma Derived Medicine Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Plasma Derived Medicine Price by Type (2017-2028) & (USD/MT)
    Figure 27. Product Picture of Hospitals
    Figure 28. Product Picture of Clinics
    Figure 29. Product Picture of Other
    Figure 30. Global Plasma Derived Medicine Market Share by Application in 2022 & 2028
    Figure 31. Global Plasma Derived Medicine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Plasma Derived Medicine Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Plasma Derived Medicine Sales by Application (2017-2028) & (K MT)
    Figure 34. Global Plasma Derived Medicine Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Plasma Derived Medicine Price by Application (2017-2028) & (USD/MT)
    Figure 36. United States Plasma Derived Medicine Market Share by Application in 2022 & 2028
    Figure 37. United States Plasma Derived Medicine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Plasma Derived Medicine Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Plasma Derived Medicine Sales by Application (2017-2028) & (K MT)
    Figure 40. United States Plasma Derived Medicine Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Plasma Derived Medicine Price by Application (2017-2028) & (USD/MT)
    Figure 42. North America Plasma Derived Medicine Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 43. North America Plasma Derived Medicine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. United States Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Mexico Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Plasma Derived Medicine Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 48. Europe Plasma Derived Medicine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. UK Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Plasma Derived Medicine Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 55. Asia-Pacific Plasma Derived Medicine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Vietnam Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Plasma Derived Medicine Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 67. Latin America Plasma Derived Medicine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Brazil Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Plasma Derived Medicine Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 70. Middle East & Africa Plasma Derived Medicine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. GCC Countries Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Egypt Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. South Africa Plasma Derived Medicine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Plasma Derived Medicine Value Chain
    Figure 76. Plasma Derived Medicine Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed